Our preliminary findings also indicate that Ang II may promote liver inflammation and the progression of NAFLD/NASH by activating NLRP3 inflammasome and its downstream inflammatory cytokines. The gene discussed is NLRP3; the disease is metabolic dysfunction-associated steatohepatitis.